Return to Search
EN
The radioactive iodine treatment process typically involves the following stages:
1. Preparation: Before starting treatment, the patient's medical history is thoroughly evaluated, and necessary diagnostic tests are performed. During this process, blood tests are requested, and imaging methods deemed appropriate, such as ultrasonography, are examined.
2. Medication Cessation: In some cases, thyroid medications may be temporarily discontinued before treatment. This is done to ensure more effective accumulation of iodine in the thyroid tissue.
3. Radioactive Iodine Administration: The patient takes radioactive iodine-131 (I-131) orally, either in capsule or liquid form. This administration usually takes place in a hospital setting, and the treatment dose is personalized by the physician according to the patient's clinical condition.
4. Isolation Period: After receiving radioactive iodine, the patient needs to be isolated for a short period. This precaution is to prevent the spread of radiation to the surroundings until the body eliminates radioactive waste. The isolation period varies depending on the administered dose and the patient's individual characteristics.
5. Follow-up and Evaluation: In the post-treatment period, the patient's recovery status is closely monitored. Doctors may perform additional tests or apply further treatments if necessary. At this stage, thyroid hormone levels, radioactive iodine scans, and other necessary examinations may be conducted.
6. Long-Term Follow-up: Following radioactive iodine treatment, patients continue with regular check-ups and follow-ups. This process can vary depending on each patient's condition and the success of the treatment but may continue for many years.
Stages of Radioactive Iodine Treatment
1. Preparation: Before starting treatment, the patient's medical history is thoroughly evaluated, and necessary diagnostic tests are performed. During this process, blood tests are requested, and imaging methods deemed appropriate, such as ultrasonography, are examined.
2. Medication Cessation: In some cases, thyroid medications may be temporarily discontinued before treatment. This is done to ensure more effective accumulation of iodine in the thyroid tissue.
3. Radioactive Iodine Administration: The patient takes radioactive iodine-131 (I-131) orally, either in capsule or liquid form. This administration usually takes place in a hospital setting, and the treatment dose is personalized by the physician according to the patient's clinical condition.
4. Isolation Period: After receiving radioactive iodine, the patient needs to be isolated for a short period. This precaution is to prevent the spread of radiation to the surroundings until the body eliminates radioactive waste. The isolation period varies depending on the administered dose and the patient's individual characteristics.
5. Follow-up and Evaluation: In the post-treatment period, the patient's recovery status is closely monitored. Doctors may perform additional tests or apply further treatments if necessary. At this stage, thyroid hormone levels, radioactive iodine scans, and other necessary examinations may be conducted.
6. Long-Term Follow-up: Following radioactive iodine treatment, patients continue with regular check-ups and follow-ups. This process can vary depending on each patient's condition and the success of the treatment but may continue for many years.